FP23
684
Dr.Shashikala P
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 2211 | Dr.Shruthi Das Shetty | shru2011@gmail.com | 9902709499 |
Cornea, Ocular Surface and External Eye Diseases
Mitomycin C – as a primary therapy in management of all cases of Ocular surface squamous neoplasia.
Purpose-Surgical excision with cryotherapy though gold standard in managing OSSN, primary medical therapy is steadily growing owing to its conservative advantages. The efficacy of topical mitomycin-C 0.04% as primary treatment for OSSN was investigated. The primary outcome measure was clinical tumor regression & secondary outcome measures included duration of treatment, side effects & recurrence. Methods -Study was on 06 patients with IC proven OSSN. All were treated with MMC eye drops 0.04% 4 times daily for 4-8weeks,weekly ON- OFF regimen with lubricants during OFF period. The study was conducted over 20months (June'24 -March'25) Results-tumor regression in 5 & reduction in 1achieved over mean duration of 6 weeks. Most common side effect was SPK, dealt with lubricants. No recurrence occurred Conclusion-Topical chemotherapy may be considered as primary treatment in all OSSN as causes complete or partial tumor regression with negligible side effects before any surgical intervention.
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 4124 | Dr.MAGI JAGAN M | magijagan@yahoo.com | 9741905017 |
| 4591 | Dr.Pooja Sajjan | poojasajjan26@gmail.com | 9740693427 |